OR WAIT null SECS
Growth and Advancements in Fill/Finish
Leveraging automation advancements can help improve efficiency in aseptic processing.
Changes and Trends in the Outsourcing Landscape
Quality Considerations in Changing Excipient Providers
February 03, 2024
This article introduces that the basic technique for tolerance interval is implemented using the conventional range 85–115% LC where the proposed range in the PF is not taken into account.
Continuous manufacturing and a quality-by-design development approach are a natural fit.
Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.
February 02, 2024
Effective analytics will eliminate failures, deviations, and non-conformances.
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
The agency will coordinate intra-regional medicines regulation to strengthen the African regulatory network.
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
The industry’s M&A activity is on the up and expected to continue to rise in 2024.
Agilent Technologies and Incyte have signed an agreement to collaborate on the development of companion diagnostics programs.